Application 761380
- Type
- BLA
- Sponsor
- BEIGENE
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | TEVIMBRA | islelizumab-jsgr | INJECTABLE;INJECTION | 10 mg/mL | Yes | No |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.